Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01115335
Other study ID # PS123541-06
Secondary ID
Status Completed
Phase Phase 4
First received April 30, 2010
Last updated July 12, 2012
Start date October 2009
Est. completion date January 2012

Study information

Verified date April 2010
Source University of Alabama at Birmingham
Contact n/a
Is FDA regulated No
Health authority Zambia: Ministry of Health
Study type Interventional

Clinical Trial Summary

In this study of neonatal male circumcision (NMC), the investigators will examine acceptability of among parents, feasibility of training providers and implementing services in various clinical settings, and the safety of service provision comparing three different surgical methods: the Gomco; the Plastibell; and the Mogen clamp. This operational study is being conducted to inform the scale up of neonatal male circumcision in Zambia.


Description:

As male circumcision becomes one component of Zambia's plan to prevent the spread of HIV, it is important to understand the acceptability, feasibility, and safety of implementing NMC services in various clinical settings.

In this study, we will examine the acceptability of neonatal male circumcision among parents in several ways. First, we will administer a structured questionnaire on NMC to 1000 consenting parents of newborn boys at a tertiary care institution and 1-2 primary care clinics in Lusaka. All parents approached, regardless of whether or not they complete the survey, will also be offered an opportunity to have their sons circumcised. Uptake will be calculated as the percent of parents approached who consent for their sons to be circumcised. Finally, we will assess parental satisfaction with results of the procedure.

To examine the feasibility of training providers and implementing neonatal male circumcision services in various clinical settings, we will train a group of 15-20 health care providers in three different circumcision methods (Gomco clamp, Mogen clamp, and Plastibell) at 2-3 study sites. We will recruit 600 infants to be circumcised during the training. We will use structured questionnaires and skill assessments to evaluate provider competence after completing the training curriculum, provider preferences among the three circumcision methods, and opinion about how NMC should be scaled up within the existing health care system. We will also document logistical difficulties of scaling up NMC services at the study sites.

Finally, we will examine the safety of implementing NMC by collecting and analyzing data on complications resulting from the different circumcision methods.


Recruitment information / eligibility

Status Completed
Enrollment 661
Est. completion date January 2012
Est. primary completion date March 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Male
Age group N/A to 28 Days
Eligibility Inclusion Criteria:

- Male infants who are in the first day of life (including infants < 24 hours old) and up to 4 weeks of age will be considered for circumcision

- Gestational age >37 weeks at birth

Exclusion Criteria:

- Any current illness

- Bleeding diathesis or family history of bleeding disorder

- Abnormality of urethra or penile shaft such as hypospadias

- Local infection defined as redness, swelling, or a purulent discharge from the infant penis

- Greater than four weeks of age

Study Design

Allocation: Non-Randomized, Endpoint Classification: Safety Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Procedure:
Neonatal male circumcision
Circumcision performed on a male infant within the first month of life, using one of 3 devices

Locations

Country Name City State
Zambia University Teaching Hospital and Matero Reference Clinic Lusaka

Sponsors (2)

Lead Sponsor Collaborator
University of Alabama at Birmingham University Teaching Hospital, Lusaka, Zambia

Country where clinical trial is conducted

Zambia, 

Outcome

Type Measure Description Time frame Safety issue
Primary Complication Rate Includes intra-operative and post-operative complications such as bleeding, infection, and cosmetic problems 0-6 weeks after the circumcision procedure Yes
Secondary Uptake of NMC Defined as % of parents of newborn boys approached during recruitment who consent to having their sons cirucumcised Ongoing, over the course of the study (1.5 years) No
Secondary Provider Preferences Measure of provider preferences among 3 circumcision devices being compared Upon completion of training in NMC No
Secondary Parent Satisfaction Score, between 0 and 100, of each parent's satisfaction with the outcome of the NMC procedure 6 weeks following the circumcision procedure No
See also
  Status Clinical Trial Phase
Completed NCT02596282 - Enhanced Provision of Male Circumcision (MC) for HIV Prevention, Rakai, Uganda Phase 2/Phase 3